CircHIPK3 relieves vascular calcification via mediating SIRT1/PGC-1α/MFN2 pathway by interacting with FUS.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 14 03 2023
accepted: 07 11 2023
medline: 29 11 2023
pubmed: 28 11 2023
entrez: 27 11 2023
Statut: epublish

Résumé

Circular RNAs (circRNAs) have been reported to regulate the biological processes of human diseases. CircHIPK3 has been implicated in vascular calcification, but the downstream regulatory mechanisms remain unclear. Our study aimed to understand the regulatory function of circHIPK3 in vascular calcification. CircHIPK3 expression in atherosclerosis (AS) serum samples and vascular smooth muscle cells (VSMCs) calcification model was assessed by quantitative real-time polymerase chain reaction (qRT-PCR). The binding relationships between fused in sarcoma (FUS) and circHIPK3 or sirtuin 1 (SIRT1) were verified by RNA immunoprecipitation (RIP) assay and RNA pull-down assays. Alkaline phosphatase (ALP) activity and alizarin red staining assays were performed to evaluate the biological effect of β-glycerophosphate (β-GP) and circHIPK3 on calcium deposition. qRT-PCR and western blot assays were used to examine the effect of β-GP, circHIPK3, SIRT1, mitofusin 2 (MFN2), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) on VSMCs calcification and the expression of calcification-related proteins. In AS serum samples and VSMCs calcification model, the expression of circHIPK3 was significantly reduced. CircHIPK3 overexpression inhibited ALP activity and calcium deposition in β-GP-induced VSMCs. Moreover, circHIPK3 could recruit FUS to further stabilize SIRT1 mRNA. CircHIPK3 promoted MFN2 expression to alleviate VSMCs calcification via activating SIRT1/PGC-1α signaling. The positive regulation of circHIPK3/FUS/SIRT1/PGC-1α/MFN2 signaling pathway contributed to the alleviate VSMCs calcification, revealing a novel regulatory axis for vascular calcification.

Sections du résumé

BACKGROUND BACKGROUND
Circular RNAs (circRNAs) have been reported to regulate the biological processes of human diseases. CircHIPK3 has been implicated in vascular calcification, but the downstream regulatory mechanisms remain unclear. Our study aimed to understand the regulatory function of circHIPK3 in vascular calcification.
METHODS METHODS
CircHIPK3 expression in atherosclerosis (AS) serum samples and vascular smooth muscle cells (VSMCs) calcification model was assessed by quantitative real-time polymerase chain reaction (qRT-PCR). The binding relationships between fused in sarcoma (FUS) and circHIPK3 or sirtuin 1 (SIRT1) were verified by RNA immunoprecipitation (RIP) assay and RNA pull-down assays. Alkaline phosphatase (ALP) activity and alizarin red staining assays were performed to evaluate the biological effect of β-glycerophosphate (β-GP) and circHIPK3 on calcium deposition. qRT-PCR and western blot assays were used to examine the effect of β-GP, circHIPK3, SIRT1, mitofusin 2 (MFN2), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) on VSMCs calcification and the expression of calcification-related proteins.
RESULTS RESULTS
In AS serum samples and VSMCs calcification model, the expression of circHIPK3 was significantly reduced. CircHIPK3 overexpression inhibited ALP activity and calcium deposition in β-GP-induced VSMCs. Moreover, circHIPK3 could recruit FUS to further stabilize SIRT1 mRNA. CircHIPK3 promoted MFN2 expression to alleviate VSMCs calcification via activating SIRT1/PGC-1α signaling.
CONCLUSION CONCLUSIONS
The positive regulation of circHIPK3/FUS/SIRT1/PGC-1α/MFN2 signaling pathway contributed to the alleviate VSMCs calcification, revealing a novel regulatory axis for vascular calcification.

Identifiants

pubmed: 38012555
doi: 10.1186/s12872-023-03602-3
pii: 10.1186/s12872-023-03602-3
pmc: PMC10683355
doi:

Substances chimiques

Calcium SY7Q814VUP
FUS protein, human 0
GTP Phosphohydrolases EC 3.6.1.-
MFN2 protein, human EC 3.6.1.-
Mitochondrial Proteins 0
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 0
RNA-Binding Protein FUS 0
SIRT1 protein, human EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-
RNA, Circular 0
HIPK3 protein, human EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

583

Subventions

Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117
Organisme : Hainan Provincial Natural Science Foundation of China
ID : 821RC1117

Informations de copyright

© 2023. The Author(s).

Références

Int J Mol Sci. 2020 Apr 13;21(8):
pubmed: 32294899
Int J Mol Sci. 2020 Feb 26;21(5):
pubmed: 32111067
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12849-12858
pubmed: 33378035
Cell Cycle. 2021 Sep;20(18):1799-1811
pubmed: 34437823
Nat Commun. 2019 Sep 20;10(1):4317
pubmed: 31541092
Toxicol Appl Pharmacol. 2013 Dec 1;273(2):345-54
pubmed: 24096033
Cell Prolif. 2021 Feb;54(2):e12964
pubmed: 33314534
Cell Death Dis. 2021 Aug 17;12(9):795
pubmed: 34404765
Biochimie. 2020 Mar;170:10-20
pubmed: 31830513
Oxid Med Cell Longev. 2018 Jun 25;2018:2876350
pubmed: 30046372
J Biol Chem. 2014 Aug 8;289(32):22048-62
pubmed: 24962570
Mol Ther Nucleic Acids. 2021 Dec 22;27:645-655
pubmed: 35036071
Front Cardiovasc Med. 2018 Dec 18;5:183
pubmed: 30619890
Calcif Tissue Int. 2013 Oct;93(4):365-73
pubmed: 23456027
J Clin Lab Anal. 2022 Jan;36(1):e24156
pubmed: 34845750
J Cell Mol Med. 2014 Sep;18(9):1863-73
pubmed: 24898700
Mol Ther Nucleic Acids. 2020 Sep 23;22:530-541
pubmed: 33230455
Exp Cell Res. 2021 Nov 15;408(2):112804
pubmed: 34487732
Circulation. 2013 Jan 22;127(3):386-96
pubmed: 23224247
Ther Adv Chronic Dis. 2015 May;6(3):84-96
pubmed: 25984289
Chin J Integr Med. 2021 Aug;27(8):597-603
pubmed: 31144160
J Biol Chem. 2010 Oct 29;285(44):33959-70
pubmed: 20817729
J Cardiovasc Transl Res. 2022 Dec;15(6):1315-1326
pubmed: 35467292
Free Radic Biol Med. 2020 Jun;153:89-102
pubmed: 32289481
Arch Med Sci. 2019 Jan;15(1):174-182
pubmed: 30697268
J Cell Mol Med. 2019 Oct;23(10):7088-7098
pubmed: 31423730
Mol Ther Nucleic Acids. 2020 Mar 6;19:31-41
pubmed: 31790973
Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):167-72
pubmed: 26522222
Aging (Albany NY). 2021 Dec 10;13(23):25241-25255
pubmed: 34887361
Sci Rep. 2019 Jan 29;9(1):878
pubmed: 30696833

Auteurs

Siyi Feng (S)

Department of Ultrasound Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan Province, China.

Youfei Qi (Y)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Zhanxiang Xiao (Z)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Hao Chen (H)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Sahua Liu (S)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Haimei Luo (H)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Hongfei Wu (H)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China.

Wenbo Zhang (W)

Department of Vascular Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19, Xiuhua Road, Haikou, 570311, Hainan Province, China. zhangwbb55@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH